SCHEMBL2402336

SCHEMBL2402336

Nc1nc(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1C=CC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.54
MTOR P42345 2/20 0.54
ALDH1A1 P00352 2/20 0.54
TP53 P04637 2/20 0.54
THRB P10828 1/20 0.54
MDM2 Q00987 1/20 0.54
NCOA1 Q15788 1/20 0.54
NCOA3 Q9Y6Q9 1/20 0.54
GMNN O75496 1/20 0.54
NFKB1 P19838 1/20 0.54
DNMT1 P26358 1/20 0.54
THPO P40225 1/20 0.54
HTT P42858 1/20 0.54
RAB9A P51151 1/20 0.54
BLM P54132 1/20 0.54
HBB P68871 1/20 0.54
PMP22 Q01453 1/20 0.54
TK2 O00142 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2402331 1.00 LMNA (0.54) LMNAMTORALDH1A1TP53THRB
SCHEMBL16631971 1.00 LMNA (0.54) LMNAMTORALDH1A1TP53THRB
SCHEMBL2587741 1.00 LMNA (0.54) LMNAMTORALDH1A1TP53THRB
SCHEMBL2587736 1.00 LMNA (0.54) LMNAMTORALDH1A1TP53THRB
SCHEMBL2583277 0.91 LMNA (0.43) LMNAMTORALDH1A1TP53THRB
SCHEMBL2583274 0.91 LMNA (0.43) LMNAMTORALDH1A1TP53THRB
SCHEMBL11328749 0.90 LMNA (0.53) LMNAMTORALDH1A1TP53THRB
SCHEMBL11324031 0.90 LMNA (0.53) LMNAMTORALDH1A1TP53THRB
SCHEMBL18080664 0.90 LMNA (0.53) LMNAMTORALDH1A1TP53THRB
SCHEMBL11328755 0.90 LMNA (0.53) LMNAMTORALDH1A1TP53THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026349-B2 Polynucleotide synthesis labeling chemistry DHARMACON, INC. (US) 2011-09-27 US disclosed
US-20080009612-A1 Novel Polynucleotide Synthesis Labeling Chemistry DHARMACON, INC. 2008-01-10 US disclosed
EP-1788875-A2 NOVEL POLYNUCLEOTIDE SYNTHESIS LABELING CHEMISTRY Dharmacon, Inc. (US) 2007-05-30 EP disclosed
WO-2006033730-A2 NOVEL POLYNUCLEOTIDE SYNTHESIS LABELING CHEMISTRY DHARMACON, INC. (US) 2006-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009612-A1 Novel Polynucleotide Synthesis Labeling Chemistry POLN, POLRMT, POLM LMNA 269/4885MTOR 3596/4885ALDH1A1 2035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.